Optiscan Imaging Limited (ASX: OIL) - Share Price

Current share price for OIL : $0.145 0.005 (3.57%)⁺

Optiscan Imaging Ltd (OIL) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a commercial stage medical technology company creating a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It developed and manufactured miniaturised digital endomicroscopes with spatial resolution of more than 1000x that of medical CT and MRI.

OIL General Information ⁺

ASX Code	OIL
Website	http://www.optiscan.com
Industry/Sector	Health Care Equipment
Market Cap ($M)	151
OIL Share Price	$0.145
Day High	$0.145
Day Low	$0.140
Last Close	$0.140
OIL Share Price Movement	$0.00 ( 3.57% )

Prices as at 14:05, 21 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Optiscan Imaging Limited (OIL) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Optiscan Imaging Limited (OIL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Optiscan Imaging Limited (OIL) price-sensitive announcements

OIL - Preliminary Final Report

The Preliminary Final Report for Optiscan Imaging Limited for the financial year ending 30

Optiscan Imaging Limited (OIL)
25 Aug 2026 | 8:45 AM

OIL - Quarterly Activities/Appendix 4C Cash Flow Report

Optiscan Imaging Limited focused on commercializing its InSpecta™ device, successfully lau

Optiscan Imaging Limited (OIL)
31 Jul 2026 | 9:18 AM

OIL - Optiscan Signs New Research Agreement for Breast Study

Optiscan Imaging Ltd has initiated a US clinical study in partnership with Mayo Clinic to

Optiscan Imaging Limited (OIL)
22 Jul 2026 | 8:25 AM

OIL - Head and Neck Study Progressing Ahead of Schedule

Optiscan Imaging Limited (ASX: OIL) has announced significant progress in their head and n

Optiscan Imaging Limited (OIL)
21 Jul 2026 | 8:33 AM

Optiscan Imaging Limited (OIL) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Change of Director's Interest Notice	16 Sep 2026 9:04AM	$0.145	$0.145	fallen by 0%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Notification of cessation of securities - OIL	16 Sep 2026 8:26AM	$0.145	$0.145	fallen by 0%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Application for quotation of securities - OIL	16 Sep 2026 8:25AM	$0.145	$0.145	fallen by 0%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Significant Milestone Reached in ACL Digital Pathology Study	10 Sep 2026 8:48AM	$0.150	$0.145	fallen by 3.33%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Change of Director's Interest Notice	10 Sep 2026 8:43AM	$0.150	$0.145	fallen by 3.33%
Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID	Health Care	$152	Application for quotation of securities - OIL	10 Sep 2026 8:40AM	$0.150	$0.145	fallen by 3.33%

OIL Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$6.99	-$0.70	-6.70%	0.00%	0.0%
2025A	-$6.31	-$0.80	2.70%	0.00%	0.0%
2024A	-$6.06	-$0.70	5.80%	0.00%	0.0%

OIL Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Cochlear Limited (COH)	$8,920M	-0.3136	0.2540	0.0785	33.2051	26.4794	24.5522	2.53%	2.63%	2.86%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$20,912M	0.1388	0.1480	0.1748	53.7577	46.8256	39.8587	1.22%	1.30%	1.47%
Optiscan Imaging Limited (OIL)	$157M	-0.0667	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
ResMed Inc. (RMD)	$18,619M	9.5922	0.0986	0.0915	20.8038	18.9373	17.3499	1.12%	1.21%	1.31%

OIL Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	7.73	0.00
Market	0.33	13.70	1.17	0.80
Sector	0.66	19.90	1.79	2.57

OIL Directors

Name	Position	Start Date
Dr Camile Farah	Chief Executive Officer, Managing Director	6 May 2021
Mr Robert Cooke	Non-Executive Chairman, Non-Executive Director	19 Apr 2021
Mr Ronnie (Ron) Song	Non-Executive Director	10 Feb 2021
Ms Karen Borg	Non-Executive Director	29 Jul 2021
Mr Sean Gardiner	Non-Executive Director	14 Jun 2022

Optiscan Imaging Limited (OIL) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
9 Sep 2026	SONG, Ronnie (Ron)	Issued	Direct Shares	230,502	$0.150	$34,575.300
9 Sep 2026	SONG, Ronnie (Ron)	Exercise	Related Securities	230,502	$0.150	$34,575.300
7 Sep 2026	COOKE, Robert	Issued	Indirect Shares	419,094	$0.150	$62,864.100

See all changes in directors' interest & trades for Optiscan Imaging Limited (OIL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

OIL Management

Name	Position
Elissa Hansen	Company Secretary

OIL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Optiscan Imaging Limited (OIL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
232,218,150 (27.80%)	Peters Investments Pty Ltd
155,109,996 (18.57%)	Orchid Capital Investments Pte Ltd
43,500,000 (5.21%)	Ibsen Pty Ltd

OIL Calendar of Events

Date	Event
24 August 2027	Report (Annual)
24 August 2027	Report (Prelim)
24 February 2027	Report (Interim)
05 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us